MoonLake Immunotherapeutics Stock Collapses. Why It’s Down 88%.

Published 1 month ago Neutral
MoonLake Immunotherapeutics Stock Collapses. Why It’s Down 88%.
Auto
The biotechnology company reported that a drug meant to treat the skin condition hidradenitis suppurativa, or HS, didn’t have a statistically significant effect.

Continue Reading

View Comments

More News

Tofutti Brands reports Q3 results

49 minutes ago Neutral

kneat.com reports Q3 results

59 minutes ago Neutral

Pacvue Strengthens EMEA Presence Through Strategic Retail Media Partnership with Tesco Media and Insights Platform

1 hour ago Positive

Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

1 hour ago Neutral

Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris

1 hour ago Neutral